Gene: UTP3
Official Full Name: UTP3 small subunit processome componentprovided by HGNC
Gene Summary: Enables RNA binding activity. Involved in ribosomal small subunit biogenesis. Located in nucleolus. Part of small-subunit processome. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO12716 | UTP3 Knockout cell line (HeLa) | Human | UTP3 | 1:3~1:6 | Negative | Online Inquiry |
KO12717 | UTP3 Knockout cell line (HCT 116) | Human | UTP3 | 1:2~1:4 | Negative | Online Inquiry |
KO12718 | UTP3 Knockout cell line (HEK293) | Human | UTP3 | 1:3~1:6 | Negative | Online Inquiry |
UTP3 Gene Knockout Cell Lines are a pivotal tool for research and biomedicine, designed to facilitate the study of gene function and regulation by providing a robust model system where the UTP3 gene has been deliberately inactivated. This gene encodes for a vital component in the processing and assembly of ribonucleoproteins, particularly within the nucleolus, thus playing a crucial role in ribosome biogenesis and cellular stress responses. The UTP3 gene knockout results in a unique cellular phenotype that allows researchers to investigate gene interactions and network pathways affecting cell growth, division, and homeostasis.
The primary mechanism of the UTP3 knockout involves the introduction of targeted gene-editing techniques, such as CRISPR-Cas9 technology, to yield cells that lack functional UTP3. This targeted approach provides researchers with a precise platform to dissect the mechanistic roles of this gene. Scientists can explore the resulting alterations in biological processes, enabling insights into diseases such as cancer and genetic disorders where dysregulation of ribosome biogenesis is implicated.
The scientific importance of UTP3 Gene Knockout Cell Lines extends to a broad range of applications, including basic research, drug discovery, and preclinical studies. Their ability to model specific genetic alterations empowers researchers to identify potential therapeutic targets and evaluate drug efficacy in a controlled environment, thus bridging the gap between basic science and clinical application.
What sets UTP3 Gene Knockout Cell Lines apart from traditional cell models is their specificity and the depth of knowledge they offer regarding the UTP3 gene's biological contributions. Unlike alternative systems, these knockout lines mitigate the variability often encountered in wild-type models, enabling more reproducible and accurate results.
For researchers and clinicians, the UTP3 Gene Knockout Cell Lines provide invaluable insights necessary for advancing knowledge in genomics and cell biology, fostering a better understanding of complex diseases. This unique product enhances experimental rigor, ultimately propelling scientific discovery forward.
Backed by years of expertise in genetic engineering and cell line development, our company is dedicated to providing high-quality, reliable biological products that meet the evolving needs of the scientific community. Our commitment to excellence ensures that researchers can trust in the integrity and performance of our UTP3 Gene Knockout Cell Lines.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.